## **Core Concept**
Digoxin toxicity can occur due to various factors that affect its pharmacokinetics or pharmacodynamics. These factors can include electrolyte imbalances, renal function, and concomitant use of other medications. Understanding these factors is crucial in managing patients on digoxin therapy.

## **Why the Correct Answer is Right**
Hypokalemia is a well-known contributor to digoxin toxicity. Digoxin and potassium compete for binding sites on the cardiac cells. When potassium levels are low, more digoxin binds to the cardiac cells, increasing the risk of toxicity. Therefore, an option that does not contribute to digoxin toxicity would be a condition or factor that does not increase the risk of toxicity.

## **Why Each Wrong Option is Incorrect**
- **Option A:** Hypokalemia contributes to digoxin toxicity by increasing the binding of digoxin to cardiac cells.
- **Option B:** Hypercalcemia can contribute to digoxin toxicity. Elevated calcium levels can increase the heart's sensitivity to digoxin, thereby increasing the risk of toxicity.
- **Option C:** Renal impairment can lead to digoxin toxicity because digoxin is primarily excreted unchanged by the kidneys. Reduced renal function can lead to elevated digoxin levels.

## **Clinical Pearl / High-Yield Fact**
A key clinical pearl is to always monitor electrolytes, especially potassium and magnesium levels, in patients on digoxin therapy. Hypokalemia and hypomagnesemia can significantly increase the risk of digoxin toxicity.

## **Correct Answer:** D.